Search results
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 3 hours agoDMD is a severe genetic disorder characterised by weakness and gradual muscle degeneration. Pfizer...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 18 hours agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 3 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 3 days agoAt the moment, Moderna’s Spikevax vaccine for Covid-19 is used in the NHS booster programmes,...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 3 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 7 days agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 3 days agoParticipants in the older group received either the new shot alone or Moderna's old COVID-19...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 3 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 18 hours agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...